# Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill

> **NCT00045799** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 354 (actual)

## Conditions studied

- Upper Gastrointestinal Bleeding

## Interventions

- **DRUG:** Omeprazole sodium bicarbonate immediate release PWD/FS
- **DRUG:** Cimetidine IV

## Key facts

- **NCT ID:** NCT00045799
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045799, "Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00045799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*